{"nct_id":"NCT05639114","title":"Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-03-02","start_date_type":"ACTUAL","primary_completion_date":"2027-04-23","primary_completion_date_type":"ESTIMATED","completion_date":"2029-04-20","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}